ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice
- PMID: 28895923
- PMCID: PMC5618212
- DOI: 10.3390/toxins9090279
ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice
Abstract
There is a geographic inequality in the incidence of colorectal cancer, lowest in developing countries, and greatest in developed countries. This disparity suggests an environmental contribution to cancer resistance in endemic populations. Enterotoxigenic bacteria associated with diarrheal disease are prevalent in developing countries, including enterotoxigenic E. coli (ETEC) producing heat-stable enterotoxins (STs). STs are peptides that are structurally homologous to paracrine hormones that regulate the intestinal guanylyl cyclase C (GUCY2C) receptor. Beyond secretion, GUCY2C is a tumor suppressor universally silenced by loss of expression of its paracrine hormone during carcinogenesis. Thus, the geographic imbalance in colorectal cancer, in part, may reflect chronic exposure to ST-producing organisms that restore GUCY2C signaling silenced by hormone loss during transformation. Here, mice colonized for 18 weeks with control E. coli or those engineered to secrete ST exhibited normal growth, with comparable weight gain and normal stool water content, without evidence of secretory diarrhea. Enterotoxin-producing, but not control, E. coli, generated ST that activated colonic GUCY2C signaling, cyclic guanosine monophosphate (cGMP) production, and cGMP-dependent protein phosphorylation in colonized mice. Moreover, mice colonized with ST-producing E. coli exhibited a 50% reduction in carcinogen-induced colorectal tumor burden. Thus, chronic colonization with ETEC producing ST could contribute to endemic cancer resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral GUCY2C-targeted agents.
Keywords: GUCY2C-cGMP axis; azoxymethane; chemoprevention; colorectal cancer; enterotoxigenic E. coli; heat-stable enterotoxins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.Infect Immun. 2016 Sep 19;84(10):3083-91. doi: 10.1128/IAI.00639-16. Print 2016 Oct. Infect Immun. 2016. PMID: 27481254 Free PMC article.
-
Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.Semin Cancer Biol. 2019 Jun;56:168-174. doi: 10.1016/j.semcancer.2018.08.011. Epub 2018 Sep 3. Semin Cancer Biol. 2019. PMID: 30189250 Review.
-
Guanylyl cyclase C signaling axis and colon cancer prevention.World J Gastroenterol. 2016 Sep 28;22(36):8070-7. doi: 10.3748/wjg.v22.i36.8070. World J Gastroenterol. 2016. PMID: 27688649 Free PMC article. Review.
-
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.Cancer Res. 2016 Jan 15;76(2):339-46. doi: 10.1158/0008-5472.CAN-15-1467-T. Cancer Res. 2016. PMID: 26773096 Free PMC article.
-
The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.Gastroenterology. 2010 Jan;138(1):241-54. doi: 10.1053/j.gastro.2009.08.064. Epub 2009 Sep 6. Gastroenterology. 2010. PMID: 19737566 Free PMC article.
Cited by
-
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.Cancer Biol Ther. 2021 Dec 2;22(10-12):544-553. doi: 10.1080/15384047.2021.1967036. Epub 2021 Oct 10. Cancer Biol Ther. 2021. PMID: 34632925 Free PMC article. Clinical Trial.
-
Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.Brain Struct Funct. 2019 Nov;224(8):2983-2999. doi: 10.1007/s00429-019-01949-y. Epub 2019 Sep 4. Brain Struct Funct. 2019. PMID: 31485718 Free PMC article.
-
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.Front Oncol. 2018 Aug 6;8:299. doi: 10.3389/fonc.2018.00299. eCollection 2018. Front Oncol. 2018. PMID: 30131940 Free PMC article. Review.
-
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.Biomark Med. 2021 Feb;15(3):201-217. doi: 10.2217/bmm-2020-0359. Epub 2021 Jan 20. Biomark Med. 2021. PMID: 33470843 Free PMC article. Review.
-
An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.Expert Rev Clin Pharmacol. 2020 Oct;13(10):1125-1137. doi: 10.1080/17512433.2020.1826304. Epub 2020 Oct 6. Expert Rev Clin Pharmacol. 2020. PMID: 32945718 Free PMC article. Review.
References
-
- Bolin I., Wiklund G., Qadri F., Torres O., Bourgeois A.L., Savarino S., Svennerholm A.M. Enterotoxigenic escherichia coli with sth and stp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers. J. Clin. Microbiol. 2006;44:3872–3877. doi: 10.1128/JCM.00790-06. - DOI - PMC - PubMed
-
- World Health Organization . World Health Organization Media Centre; [(accessed on 7 September 2017)]. Diarrhoeal Disease Fact Sheet, 2009. Available online: http://www.who.int/mediacentre/factsheets/fs330/en/
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical